Bionomics Ltd ADR

$ 0.25

0.00%

08 May - close price

  • Market Cap 4,954,900 USD
  • Current Price $ 0.25
  • High / Low $ 0.25 / 0.25
  • Stock P/E N/A
  • Book Value 1.32
  • EPS -14.32
  • Next Earning Report -
  • Dividend Per Share N/A
  • Dividend Yield 0 %
  • Next Dividend Date -
  • ROA -0.40 %
  • ROE -0.78 %
  • 52 Week High 0.00
  • 52 Week Low 0.00

About

Bionomics Ltd ADR (BNOX) is a clinical-stage biopharmaceutical company at the forefront of developing innovative therapies for central nervous system (CNS) disorders and cancer. Utilizing its proprietary drug discovery platform, the company is advancing a robust pipeline of candidates, including lead programs aimed at treating anxiety and cognitive impairment related to Alzheimer's disease. Bionomics is strategically positioned in the competitive biotech landscape, driven by its commitment to fulfilling significant unmet medical needs through collaborations and targeted research initiatives. By focusing on transformative solutions, Bionomics aspires to improve patient outcomes, thereby enhancing shareholder value in the process.

Analyst Target Price

$9.74

Quarterly Earnings

Sep 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021
Reported Date 2024-11-272024-05-032024-03-152023-11-292023-09-122023-05-312023-02-232022-11-302022-08-292022-06-012022-02-222021-12-01
Reported EPS -0.05200000-0.6642-0.6992-97.2-102.6-0.51-0.8096
Estimated EPS None-0.5815-0.6343-0.5947-0.262-0.4614-0.6642-0.684-0.85-0.5497-1.020
Surprise 00.58150.63430.59470.2620.46140-0.0152-96.35-102.05030.51-0.8096
Surprise Percentage None%100%100%100%100%100%0%-2.2222%-11335.2941%-18564.7262%50%None%

Next Quarterly Earnings

Reported Date
Fiscal Date Ending
Estimated EPS
Currency

Next Dividend Records

Dividend per share (year): -
Dividend Yield -
Next Dividend Date -
Ex-Dividend Date -

Iscriviti alla nostra newsletter

Email Subscription Form


Resta aggiornato. Ricevi tutti i nuovi articoli e le notizie ogni settimana.
banner startinvesting

Questo si chiuderà in 0 secondi